ARTIOS

Study Information

Status: Completed

Study Details

View study details on clinicaltrials.gov.

Locations

Not Specified

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.

Location: PAMF (Peninsula/South Bay/Santa Cruz)

Please contact: Renee Kaneshiro at kaneshr@pamf.org about Artios

Principal Investigator

Minal Bhanushali, MD, PAMFRI Medical Director, Ariele L Greenfield, M.D., Director of PAMF Multiple Sclerosis Center

Related Studies

Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care

Create a longitudinal proof-of-concept MS research database (MSClinQ) that can support clinical queries, and can be updated with new tx, dx tools, care options

Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA

Using Mobile Technology and Analytics to Track Outcomes in MS Patients

Develop an app to collect and transform pt-reported outcomes in MS for health care providers to improve care and support shared decision making.

Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS

Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)

Develop an app that support access to clinical data and shared decision-making, predict disease course, and guide disease management.

Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA